Benjamin L. Palleiko

Companies

• KalVista Pharmaceuticals, Inc.Board member Mar 8, 2024 to now¹
• KalVista Pharmaceuticals, Inc.Chief executive officer Mar 8, 2024 to now¹
• KalVista Pharmaceuticals, Inc.Chief financial officer Nov 28, 2016 to Feb 21, 2024²
• KalVista Pharmaceuticals, Inc.President Feb 23, 2023 to Nov 21, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKalVista Pharmaceuticals, Inc.0 shares⁴Jun 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2026Returned to company 479,989 shares of KalVista Pharmaceuticals, Inc.⁴
• May 22, 2026Sold 10,926 shares at $26.78 of KalVista Pharmaceuticals, Inc.⁵
• May 21, 2026Exercised options 23,250 shares of KalVista Pharmaceuticals, Inc.⁵
• May 18, 2026Sold 1,129 shares at $26.76 of KalVista Pharmaceuticals, Inc.⁶
• May 17, 2026Exercised options 2,419 shares of KalVista Pharmaceuticals, Inc.⁶
• May 12, 2026Sold 3,322 shares at $26.71 of KalVista Pharmaceuticals, Inc.⁷
• May 11, 2026Exercised options 7,120 shares of KalVista Pharmaceuticals, Inc.⁷
• Apr 17, 2026Sold 9,550 shares at $20.22 of KalVista Pharmaceuticals, Inc.⁸
• Apr 16, 2026Exercised options 20,312 shares of KalVista Pharmaceuticals, Inc.⁸
• Mar 9, 2026Sold 6,693 shares at $16.08 of KalVista Pharmaceuticals, Inc.⁹
• Mar 6, 2026Exercised options 15,625 shares of KalVista Pharmaceuticals, Inc.⁹
• Feb 23, 2026Sold 10,034 shares at $15.57 of KalVista Pharmaceuticals, Inc.¹⁰
• Feb 21, 2026Exercised options 23,250 shares of KalVista Pharmaceuticals, Inc.¹⁰
• Feb 18, 2026Sold 1,038 shares at $15.00 of KalVista Pharmaceuticals, Inc.¹¹
• Feb 17, 2026Exercised options 2,419 shares of KalVista Pharmaceuticals, Inc.¹¹
• Feb 12, 2026Sold 3,354 shares at $15.70 of KalVista Pharmaceuticals, Inc.¹²
• Feb 11, 2026Exercised options 7,120 shares of KalVista Pharmaceuticals, Inc.¹²
• Dec 8, 2025Sold 7,294 shares at $16.51 of KalVista Pharmaceuticals, Inc.¹³
• Dec 6, 2025Exercised options 15,625 shares of KalVista Pharmaceuticals, Inc.¹³
• Nov 24, 2025Sold 10,940 shares at $13.45 of KalVista Pharmaceuticals, Inc.¹⁴
• Nov 21, 2025Exercised options 23,250 shares of KalVista Pharmaceuticals, Inc.¹⁴
• Nov 18, 2025Sold 4,466 shares at $14.48 of KalVista Pharmaceuticals, Inc.¹⁵
• Nov 17, 2025Exercised options 9,364 shares of KalVista Pharmaceuticals, Inc.¹⁵
• Nov 12, 2025Sold 3,328 shares at $11.55 of KalVista Pharmaceuticals, Inc.¹⁶
• Nov 11, 2025Exercised options 7,120 shares of KalVista Pharmaceuticals, Inc.¹⁶